Prognostic impact of HER2 overexpression/amplification in women with pT1a NO MO breast cancer with known screening status: Results from a multicenter population-based cancer registry study

被引：0
|
作者：
Musolino, A.
Michiara, M.
Boggiani, D.
Sikokis, A.
Rimanti, A.
Pellegrino, B.
Silini, E. M.
Campanini, N.
Barbieri, E.
Sgargi, P.
Falcini, F.
Pinto, C.
机构：
[1] Univ Hosp Parma, Med Oncol Unit, Parma, Italy
[2] Univ Hosp Parma, Canc Registry Parma Prov, Parma, Italy
[3] Univ Hosp Parma, Sect Anat & Pathol, Parma, Italy
[4] St Orsola Marcello Malpighi Hosp, SSD Oncol Med Addarii, Bologna, Italy
[5] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori, Romagna Tumor Registry, Meldola, Italy
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P1-07-23
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-07-23
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prognostic impact of HER2 overexpression/amplification in women with pT1a N0 M0 breast cancer with known screening status: First results from a multicenter population-based cancer registry study.
    Musolino, Antonino
    Michiara, Maria
    Boggiani, Daniela
    Sikokis, Angelica
    Rimanti, Anita
    Pellegrino, Benedetta
    Martella, Eugenia
    Bozzani, Francesco
    Sgargi, Paolo
    Panebianco, Michele
    Bisagni, Giancarlo
    Falcini, Fabio
    Pinto, Carmine
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study
    Musolino, A.
    Falcini, F.
    Sikokis, A.
    Boggiani, D.
    Rimanti, A.
    Pellegrino, B.
    Silini, E. M.
    Campanini, N.
    Barbieri, E.
    Zamagni, C.
    Esposti, R. Degli
    Cortesi, L.
    Bisagni, G.
    Cavanna, L.
    Frassoldati, A.
    Sgargi, P.
    Michiara, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 88 : 10 - 20
  • [3] Prognostic Impact of Interval Breast Cancer Detection in Women with pT1aN0M0 Breast Cancer with HER2-positive Status: Results from a Multicenter Population-based Cancer Registry Study
    Boggiani, D.
    Sikokis, A.
    Rimanti, A.
    Pellegrino, B.
    Silini, E. M.
    Campanini, N.
    Barbieri, E.
    Cortesi, L.
    Panebianco, M.
    Porzio, R.
    Frassoldati, A.
    Sgargi, P.
    Falcini, F.
    Michiara, M.
    Musolino, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study
    Musolino, A.
    Sikokis, A.
    Boggiani, D.
    Rimanti, A.
    Pellegrino, B.
    Silini, E. M.
    Campanini, N.
    Barbieri, E.
    Cortesi, L.
    Panebianco, M.
    Porzio, R.
    Frassoldati, A.
    Sgargi, P.
    Falcini, F.
    Michiara, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Prognostic role of HER2 expression in patients with ER-positive/HER2-negative breast cancer: Results from a population-based cancer registry study
    Musolino, A.
    Serra, O.
    Pellegrino, B.
    Tommasi, C.
    Zanoni, D.
    Faccini, F.
    Michiara, M.
    Sgargi, P.
    Carrozzi, G.
    Ferretti, S.
    Grossi, V.
    Ravaioli, A.
    Zamagni, F.
    Falcini, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S298 - S299
  • [6] Prognostic Role of HER2 Expression in Patients with ER- positive/HER2-negative Breast Cancer. Results from a Population-Based Cancer Registry Study
    Musolino, Antonino
    Serra, Olga
    Pellegrino, Benedetta
    Tommasi, Chiara
    Zanoni, Daniele
    Faccini, Fabio
    Michiara, Maria
    Sgargi, Paolo
    Carrozzi, Giuliano
    Ferretti, Stefano
    Grossi, Veruska
    Ravaioli, Alessandra
    Zamagni, Federica
    Falcini, Fabio
    CANCER RESEARCH, 2024, 84 (09)
  • [7] Prognostic role of HER2 expression in patients with ER-positive/HER2-negative breast cancer: Results from a population-based cancer registry study.
    Musolino, Antonino
    Serra, Olga
    Pellegrino, Benedetta
    Tommasi, Chiara
    Zanoni, Daniele
    Cortesi, Laura
    Canino, Fabio
    Piacentini, Federico
    Sgargi, Paolo
    Michiara, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Effects of HER2 status on the prognosis of male breast cancer: a population-based study
    Chen, Liang
    Weng, Yi Ming
    Hu, Meng Xue
    Peng, Min
    Bin Song, Qi
    ONCOTARGETS AND THERAPY, 2019, 12 : 7251 - 7260
  • [9] Stage IV breast cancer: a population-based study about prognostic factors according to HER2 and HR status
    Bertaut, A.
    Mounier, M.
    Desmoulins, I.
    Guiu, S.
    Beltjens, F.
    Darut-Jouve, A.
    Ponnelle, T.
    Arnould, L.
    Arveux, P.
    EUROPEAN JOURNAL OF CANCER CARE, 2015, 24 (06) : 920 - 928
  • [10] HER2/NEU OVEREXPRESSION IN pT1a OR pT1b, N0, M0 BREAST CANCER
    Petroni, S.
    Asselti, M.
    Giotta, F.
    Quero, C.
    D'Amico, C.
    Marzano, A. L.
    Daprile, R.
    Salvatore, C.
    Colucci, G.
    Simone, G.
    CANCER TREATMENT REVIEWS, 2010, 36 : S103 - S103
12345